Skip to main content
    C

    CryoCell International Inc (CCEL)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • AMEX

    $4.52
    -0.33 (-6.80%)

    Market Cap: $39.10M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CryoCell International Inc (CCEL) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    CryoCell International (CCEL) trades at 1.2x sales. Its P/S of 1.2x is below its 5-year median of 1.4x.

    Current Multiples

    Its enterprise value is 34.3x its EBITDA. Its free cash flow yield is 12.8%.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales1.2x
    EV/EBITDA34.3x
    Price to FCF7.8x
    EV/FCF9.5x
    PEGN/A
    FCF yield12.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 33.3% below 1.8x.

    MultipleCurrent5-year median10-year median
    P/S1.2x1.4x1.8x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 119 months (10-year).

    Valuation History

    Over the 5 of the 9 year ends shown that have a P/E, its P/E ranged from 12.8x in 2022 to 98.1x in 2024. 2024 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$3.44N/A0.9xN/A
    2024$7.4198.1x1.9xN/A
    2023$5.75N/A1.5xN/A
    2022$4.2312.8x1.2xN/A
    2021$11.6046.4x3.2x23.2x
    2020$7.7017.1x1.9xN/A
    2019$7.13N/A1.7xN/A
    2017$9.6714.0x2.6xN/A
    2016$4.56N/A1.6xN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    Frequently Asked Questions About CCEL

    What is CCEL's price to sales ratio?

    CryoCell International has a price to sales ratio of 1.2x.